Till Krech

5.0k total citations
79 papers, 1.9k citations indexed

About

Till Krech is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Till Krech has authored 79 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 23 papers in Oncology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Till Krech's work include Prostate Cancer Treatment and Research (13 papers), Liver Diseases and Immunity (12 papers) and Liver Disease Diagnosis and Treatment (11 papers). Till Krech is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Liver Diseases and Immunity (12 papers) and Liver Disease Diagnosis and Treatment (11 papers). Till Krech collaborates with scholars based in Germany, United States and Netherlands. Till Krech's co-authors include Ulrich Lehmann, Hans Kreipe, Ansgar W. Lohse, Elisa Schipper, Britta Hasemeier, Arndt Vogel, Guido Sauter, Nóra Schweitzer, Sumadi Lukman Anwar and Michael P. Manns and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Till Krech

77 papers receiving 1.8k citations

Peers

Till Krech

HEPAT

EPIDE

ONCOL

Orlando Musso France

Abeer A. Bahnassy Egypt

Jianming Zheng China

Xin Yin China

Naoki Oishi Japan

Wang Li China

Tom M. Ganten Germany

Stefania Brozzetti Italy

Miroslaw Kornek Germany

Hidetoshi Nitta Japan

Orlando Musso France

Till Krech

812 ×1.0

478 ×0.9

403 ×0.8

HEPAT

286 ×0.6

EPIDE

427 ×0.9

ONCOL

Citations per year, relative to Till Krech Till Krech (= 1×) peers Orlando Musso

Countries citing papers authored by Till Krech

Since Specialization

Citations

This map shows the geographic impact of Till Krech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Till Krech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Till Krech more than expected).

Fields of papers citing papers by Till Krech

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Till Krech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Till Krech. The network helps show where Till Krech may publish in the future.

Co-authorship network of co-authors of Till Krech

This figure shows the co-authorship network connecting the top 25 collaborators of Till Krech. A scholar is included among the top collaborators of Till Krech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Till Krech. Till Krech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Viehweger, Florian, Franziska Büscheck, Till S. Clauditz, et al.. (2024). Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 Tumors. Biomedicines. 12(5). 957–957. 3 indexed citations

Hartl, Johannes, Malte H. Wehmeyer, Marcial Sebode, et al.. (2023). Right and left liver lobe biopsies by minilaparoscopy reveal clinically significant sampling error in staging and grading of autoimmune hepatitis. Liver International. 43(6). 1269–1276. 6 indexed citations

Lennartz, Maximilian, Florian Viehweger, David Dum, et al.. (2023). Abstract 5457: Prevalence of “low” HER2 expression is frequent in breast cancer but also in cancers of other origin: A tissue microarray study on 131 tumor types. Cancer Research. 83(7_Supplement). 5457–5457. 1 indexed citations

Johanning, Kai, et al.. (2022). Interleukin-18 and High-Mobility-Group-Protein B1 are Early and Sensitive Indicators for Cell Damage During Normothermic Machine Perfusion after Prolonged Cold Ischemic Storage of Porcine Liver Grafts. Transplant International. 35. 10712–10712. 5 indexed citations

Schmalfeldt, Barbara, Volkmar Müller, Linn Wölber, et al.. (2021). MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancer. Pathology - Research and Practice. 224. 153533–153533. 3 indexed citations

Zachou, Kalliopi, Simon Pape, Elmar Jaeckel, et al.. (2021). Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis. JHEP Reports. 3(4). 100321–100321. 27 indexed citations

Hartl, Johannes, Rosa Miquel, Kalliopi Zachou, et al.. (2020). Features and outcome of AIH patients without elevation of IgG. JHEP Reports. 2(3). 100094–100094. 34 indexed citations

Krause, Jenny, Johann von Felden, Christian Casar, et al.. (2020). Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype. BMC Cancer. 20(1). 1130–1130. 18 indexed citations

Barikbin, R, Gevitha Ravichandran, Till Krech, et al.. (2019). Deletion of tumour necrosis factor α receptor 1 elicits an increased TH17 immune response in the chronically inflamed liver. Scientific Reports. 9(1). 4232–4232. 11 indexed citations

10.

Brinkert, Florian, et al.. (2016). Two Cases of Hepatosplenic T-Cell Lymphoma in Adolescents Treated for Autoimmune Hepatitis. PEDIATRICS. 138(3). 10 indexed citations

11.

Loga, Katharina von, Lia Burkhardt, Ronald Simon, et al.. (2015). FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma. PLoS ONE. 10(11). e0141867–e0141867. 17 indexed citations

12.

Melling, Nathaniel, Claudia Hube‐Magg, Martina Kluth, et al.. (2015). High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer. PLoS ONE. 10(7). e0134614–e0134614. 14 indexed citations

13.

Schwinge, Dorothee, Antonella Carambia, Alexander Quaas, et al.. (2015). Testosterone Suppresses Hepatic Inflammation by the Downregulation of IL-17, CXCL-9, and CXCL-10 in a Mouse Model of Experimental Acute Cholangitis. The Journal of Immunology. 194(6). 2522–2530. 58 indexed citations

14.

Kleine, Moritz, Till Krech, Mark D. Jäger, et al.. (2014). Explanted Diseased Livers – A Possible Source of Metabolic Competent Primary Human Hepatocytes. PLoS ONE. 9(7). e101386–e101386. 51 indexed citations

15.

Quaas, Alexander, et al.. (2014). Frequency of TERT promoter mutations in primary tumors of the liver. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(6). 673–677. 57 indexed citations

16.

John, Katharina, Johannes Hadem, Till Krech, et al.. (2014). MicroRNAs play a role in spontaneous recovery from acute liver failure. Hepatology. 60(4). 1346–1355. 74 indexed citations

17.

Marhenke, Silke, Laura Elisa Buitrago‐Molina, Jessica Endig, et al.. (2013). p21 promotes sustained liver regeneration and hepatocarcinogenesis in chronic cholestatic liver injury. Gut. 63(9). 1501–1512. 43 indexed citations

18.

Christgen, Matthias, Elisa Schipper, Henriette Christgen, et al.. (2012). Oncogenic PIK3CA mutations in lobular breast cancer progression. Genes Chromosomes and Cancer. 52(1). 69–80. 30 indexed citations

19.

Krech, Till, et al.. (2011). ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells. Cancer Letters. 315(2). 153–160. 36 indexed citations

20.

Christgen, Matthias, Matthias Ballmaier, Till Krech, et al.. (2008). KAI1/CD82 is a novel target of estrogen receptor‐mediated gene repression and downregulated in primary human breast cancer. International Journal of Cancer. 123(10). 2239–2246. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact